FINPROM Findings
3“MicroSalt® is more than a healthier alternative-it is a disruptive, category-defining solution poised to deliver significant commercial and societal impact... projected revenues of in hand volume requirements totalling $7.0 million in 2026 and over $15.0 million in 2027”
Heavily promotional language ('disruptive, category-defining', 'ideally positioned for scale and market leadership', '$10+ billion global salt market') alongside specific unqualified revenue projections ($7m 2026, $15m+ 2027) in a fundraising announcement. While forward-looking disclaimers exist later in the document, the projections in the body are presented as near-certainties.
“Retail Offer opens 9 December 2025, 4:35 p.m... Retail Offer is expected to close at 12:00 p.m. on 12 December 2025”
Retail offer window of approximately 3 calendar days (2 full business days). The compressed timeline is mitigated by adequate risk warnings and forward-looking disclaimers in the retail offer RNS itself.
“"THE COMMUNICATION OF THIS ANNOUNCEMENT AND ANY OTHER DOCUMENTS OR MATERIALS RELATING TO THE RETAIL OFFER AS A FINANCIAL PROMOTION IS ONLY BEING MADE TO... THOSE PERSONS IN THE UNITED KINGDOM FALLING WITHIN ARTICLE 43"”
Retail offer announcement follows standard compliant format with Article 43 restrictions, risk warnings, minimum £100 subscription, and appropriate disclaimers. Discount of 13.5% is clearly disclosed.
RNS Announcements
2Subscription to raise £1.5 million
this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as imported into the laws of England and Wales by virtue of the European Union (Withdrawal) Act 2018 (as amended) and certain other enacting measures ("UK MAR"). With the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain. 9 December 2025 MicroSalt Plc ("MicroSalt" or the "Company") Subscription to raise £1.5 million MicroSalt plc (AIM:SALT…
Launch of Retail Offer
THIS ANNOUNCEMENT. THE COMMUNICATION OF THIS ANNOUNCEMENT AND ANY OTHER DOCUMENTS OR MATERIALS RELATING TO THE RETAIL OFFER AS A FINANCIAL PROMOTION IS ONLY BEING MADE TO, AND MAY ONLY BE ACTED UPON BY, THOSE PERSONS IN THE UNITED KINGDOM FALLING WITHIN ARTICLE 43 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (WHICH INCLUDES AN EXISTING MEMBER OF MICROSALT PLC). ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT RELATES IS AVAILABLE ONLY TO SUCH PERSONS AND WILL BE ENGAGED IN ONLY BY SUCH PERSONS. THIS ANNOUNCEMENT IS FOR INFORMATIO…
LinkedIn Activity
2MicroSalt celebrated First Day of Dealings on LSE under ticker SALT. Referenced WHO ambitions for 30% sodium reduction by 2025. Positioned product as meeting growing demand for lower sodium products.
IPO announcement post. No financial details disclosed (no mention of £18.5m valuation or £3m raised). Forward-looking health claims without disclaimers. No 'disruptive category-defining' language in this specific post.
MicroSalt PLC debuted on AIM with £18.5m valuation, raising £3m. Shares at 43p under SALT ticker. CEO Rick Guiney quoted on successful fundraise. Shares up 20% to 52p by Friday.
News coverage of IPO. Factual reporting with CEO quote. No risk warnings.